14 January 2021
Maxwellia Announces Appointment of Jack Grimshaw as Finance Director
Maxwellia, the UK’s only dedicated expert medicines switching company, has appointed Jack Grimshaw as Finance Director, with broader accountability for Supply Chain & Logistics, Procurement, IT, Legal & HR. The appointment is a reflection of the company’s...
12 January 2021
Funding package announced for blister prevention firm Pellitec
The North West entrepreneurs behind PelliTec®, the innovative blister prevention pad, are celebrating as the National Institute of Health Research has awarded the company a grant to progress a ‘proof of concept’ study at Sheffield Teaching Hospitals NHS...
7 January 2021
Kite and Oxford Biotherapeutics Establish Cell therapy Research Collaboration in Blood Cancers and Solid Tumours
Santa Monica, Calif.; Oxford, UK; and San Jose, Calif., January 6, 2021 - Kite, a Gilead Company (Nasdaq: GILD), and Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug conjugate (ADC)-based therapies...
5 January 2021
Panthera assists in AstraZeneca’s phase III trial of antibody combination for prevention of Covid-19
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The...
4 January 2021
British MedTech Rinicare poised to respond to the challenges of the new healthcare environment
Manchester based clinician-led digital health company, Rinicare, has further strengthened its foundations with the appointment of a new Managing Director and the closure of a finance round, which included investment from the Future Fund along with Mercia Asset Management and...